Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q2 EPS of ($0.53), $0.04 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.